• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Health Tip: Nasal Spray Safety

drugsJune 06, 2019

Tag: nasal , Spray , safety , guideline

For people who use nasal sprays to combat seasonal allergies, it's important to follow safety guidelines, says the Allergy & Asthma Network.

When using a nasal spray. you should:

Aim away from the center of your nose.

Always follow the package instructions, as brands vary.

Blow your nose gently before use.

Wipe the spray tip clean after every use.

Keep track of the doses used.

Replace the spray when instructed.

Register as Visitor to CPhI China 2019 NOW!

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:Many Dietary Supplements Dangerous for Teens

Next:Health Tip: Causes of Hair Loss

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Health Tip: Nasal Spray Safety | Pharmasources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

HDPE spray bottle xinjitai YY129-50

HDPE spray bottle xinjitai YY129-50
Medicine Spray Pump bottle PE spray bottle xinjitai PE bottlesYY083-10

Medicine Spray Pump bottle PE spray bottle xinjitai PE bottlesYY083-10
PET plastic spray bottle xinjitai YY057-30

PET plastic spray bottle xinjitai YY057-30
Equipment for spraying and rolling fluorine materials and steel parts

Equipment for spraying and rolling fluorine materials and steel parts
Topical SprayerXH351-20-410

Topical SprayerXH351-20-410
HDPE spray bottle xinjitai YY155-15

HDPE spray bottle xinjitai YY155-15
plastic spray bottle nasal spray pump bottle oral spray pump bottle YY528-25

plastic spray bottle nasal spray pump bottle oral spray pump bottle YY528-25
Formaldehyde Silicic Acid Spraying Machine

Formaldehyde Silicic Acid Spraying Machine
Nose Sprayer Nasal Mist Sprayer Nasal Mist Spray Pump Nasal Sprayer nasal spray pump XB042-18-415

Nose Sprayer Nasal Mist Sprayer Nasal Mist Spray Pump Nasal Sprayer nasal spray pump XB042-18-415
spray bottle PET plastic spray bottle Pharmaceutical xinjitai PET bottlesYY057-30

spray bottle PET plastic spray bottle Pharmaceutical xinjitai PET bottlesYY057-30

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service